xCT, not just an amino-acid transporter: a multi-functional regulator of microbial infection and associated diseases

被引:17
|
作者
Dai, Lu [1 ,2 ,3 ]
Noverr, Mairi C. [4 ]
Parsons, Chris [3 ]
Kaleeba, Johnan A. R. [5 ]
Qin, Zhiqiang [1 ,2 ,6 ]
机构
[1] Tongji Univ, East Hosp, Sch Med, Res Ctr Translat Med, Shanghai, Peoples R China
[2] Tongji Univ, East Hosp, Sch Med, Key Lab Arrhythmias,Minist Educ Chiha, Shanghai, Peoples R China
[3] Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Med, New Orleans, LA USA
[4] Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Oral & Craniofacial Biol, New Orleans, LA USA
[5] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA
[6] Louisiana State Univ, Hlth Sci Ctr, Louisiana Canc Res Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA
关键词
KSHV; virus; bacteria; xCT; cysteine; glutamate; CYSTINE TRANSPORTER; DNA-SEQUENCES; ENDOTHELIAL-CELLS; SYSTEM X(C)(-); L-GLUTAMATE; CANCER; SULFASALAZINE; RESISTANCE; INDUCTION; PATHOGENESIS;
D O I
10.3389/fmicb.2015.00120
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Expression of xCT, a component of the x(c)(-) amino-acid transporter, is essential for the uptake of cystine required for intracellular glutathione (GSH) synthesis and maintenance of the intracellular redox balance. Therefore, xCT plays an important role not only in the survival of somatic and immune cells, but also in other aspects of tumorigenesis, including the growth and malignant progression of cancer cells, resistance to anticancer drugs, and protection of normal cells against oxidative damage induced by carcinogens. xCT also functions as a factor required for infection by Kaposi's sarcoma-associated herpesvirus (KSHV), the causative agent of Kaposi's sarcoma (KS) and other lymphoproliferative diseases associated with HIV/AIDS. In spite of these advances, our understanding of the role of xCT in the pathogenesis of infectious diseases is still limited. Therefore, this review will summarize recent findings about the functions of xCT in diseases associated with microbial (bacterial or viral) infections, in particular KSHV-associated malignancies. We will also discuss the remaining questions, future directions, as well as evidence that supports the potential benefits of exploring system x(c)(-) as a target for prevention and clinical management of microbial diseases and cancer.
引用
收藏
页数:5
相关论文
共 4 条
  • [1] Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer
    Toyoda, M.
    Kaira, K.
    Ohshima, Y.
    Ishioka, N. S.
    Shino, M.
    Sakakura, K.
    Takayasu, Y.
    Takahashi, K.
    Tominaga, H.
    Oriuchi, N.
    Nagamori, S.
    Kanai, Y.
    Oyama, T.
    Chikamatsu, K.
    BRITISH JOURNAL OF CANCER, 2014, 110 (10) : 2506 - 2513
  • [2] Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer
    M Toyoda
    K Kaira
    Y Ohshima
    N S Ishioka
    M Shino
    K Sakakura
    Y Takayasu
    K Takahashi
    H Tominaga
    N Oriuchi
    S Nagamori
    Y Kanai
    T Oyama
    K Chikamatsu
    British Journal of Cancer, 2014, 110 : 2506 - 2513
  • [3] Positive correlation of expression of L-type amino-acid transporter 1 with colorectal tumor progression and prognosis: Higher expression in sporadic colorectal tumors compared with ulcerative colitis-associated neoplasia
    Sakata, Takeshi
    Hana, Kiyomi
    Mikami, Tetuo
    Yoshida, Tutomu
    Endou, Hitoshi
    Okayasu, Isao
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (06)
  • [4] Multi-omics integration analysis of the amino-acid metabolism-related genes identifies putatively causal variants of ACCS associated with hepatitis B virus-related hepatocellular carcinoma survival
    Wei, Xiaoxia
    Yang, Xiaobing
    Duan, Shuangdi
    Lin, Qiuling
    Qiu, Moqin
    Wen, Qiuping
    Mo, Qiuyan
    Zhou, Zihan
    Jiang, Yanji
    Chen, Peiqin
    Liang, Xiumei
    Cao, Ji
    Guo, Qian
    Yu, Hongping
    Liu, Yingchun
    BMC CANCER, 2025, 25 (01)